| Literature DB >> 32252275 |
Tse-Hao Chen1, Wan-Ting Liao2,3, Chien-Sheng Chen4,5, Po-Chen Lin4,5, Meng-Yu Wu4,5.
Abstract
Envenoming syndrome is a systemic reaction induced by inoculation of large volumes of Hymenoptera venom. The clinical manifestations range from skin allergic reactions to multiple organ failure. Vespid venom-induced toxic reactions and anaphylaxis are the most common lethal mechanism of death, involving acute respiratory failure, acute liver failure, rhabdomyolysis, acute kidney injury, and severe coagulopathy. Multiple organ failure as a consequence of severe venom toxicity is a rare but dangerous complication in victims. Delay of intervention to correct vespid venom-induced toxic reactions may cause catastrophic complications. Here, we describe a case presenting a rare vespid venom-induced multiple organ failure with systemic coagulopathy after massive Vespa attack.Entities:
Keywords: acute kidney injury; acute liver failure; bee; multiple organ failure; rhabdomyolysis
Year: 2020 PMID: 32252275 PMCID: PMC7240471 DOI: 10.3390/insects11040219
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 2.769
Figure 1(A–C) An erythematous rash with central necrosis and local tenderness was noted over the face, abdomen, and extremities. (D) Acute gross hematuria occurred after admission.
The laboratory evaluation of this patient.
| Variables | Normal Range | Patient Data | ||||||
|---|---|---|---|---|---|---|---|---|
| Day 1 | Day 2 | Day 3 | Day 4 | Day 7 | Day 8 | Day 10 | ||
| White cell count | 3.9–10.6 (× 103/µL) | 17.42 | 23.07 | 21.02 | --- | 20.45 | --- | 18.54 |
| Hemoglobin | 13.5–17.5 g/dL | 17.0 | 15.8 | 12.0 | --- | 9.0 | --- | 7.7 |
| Platelet counts | 150–400 (× 103/µL) | 299 | 241 | 132 | --- | 104 | --- | 190 |
| Band | 0–3% | 0.0 | 10.0 | 5.0 | --- | 5.0 | --- | 0.0 |
| Monocyte | 2–10% | 5.0 | 7.0 | 3.0 | --- | 9.0 | --- | 7.0 |
| Neutrophile | 40–75% | 54.0 | 73.0 | 87.0 | --- | 80.0 | --- | 80.0 |
| Lymphocyte | 20–45% | 39.0 | 9.0 | 4.0 | --- | 4.0 | --- | 8.0 |
| Eosinophile | 1–6% | 0.0 | 0.0 | 0.0 | --- | 0.0 | --- | 2.0 |
| PT | 8–12 sec | 127.2 | 14.8 | 12.3 | --- | --- | --- | --- |
| APTT | 23.9–35.5 sec | 58.1 | 67.6 | 35.4 | --- | --- | --- | --- |
| INR | ---- | 14.51 | 1.48 | 1.22 | --- | --- | --- | --- |
| FDP-D-dimer | 0–500 µg/L | 857.92 | --- | --- | --- | --- | --- | --- |
| Fibrinogen | 200-400 mg/dL | 218.9 | --- | --- | --- | --- | --- | --- |
| Creatinine | 0.7–1.3 mg/dL | 1.2 | 3.3 | 5.3 | 5.9 | 9.2 | --- | 8.3 |
| Sodium | 136–145 mmole/L | 135 | 131 | 131 | 136 | 136 | --- | 141 |
| Potassium | 3.5–5.1 mmole/L | 3.7 | 4.8 | 4.4 | 4.5 | 5.4 | --- | 4.1 |
| LDH | 85-227 IU/L | 2318 | --- | --- | --- | --- | --- | --- |
| Glucose | 3.9–5.6 mmole/L | 158 | --- | --- | --- | --- | --- | --- |
| ALT | 16–63 U/L | 531 | 1541 | 917 | 542 | 221 | --- | 110 |
| AST | 15–37 U/L | 1782 | --- | 2034 | 374 | 49 | --- | 25 |
| Creatine kinase | 39–308 IU/L | 324 | 15,439 | 12,210 | 6218 | 619 | --- | 179 |
| CKMB | 7–25 IU/L | 149 | 313 | --- | --- | --- | --- | --- |
| Total bilirubin | 0.0–1.0 mg/dL | 5.48 | 9.15 | 2.67 | 1.70 | 0.79 | --- | 1.01 |
| Direct bilirubin | 0.0–0.3 mg/dL | 0.24 | --- | 0.88 | --- | --- | --- | --- |
| Myoglobin | 17.4–105.7 ng/mL | ---- | >3893 | >3893 | --- | --- | --- | --- |
| pH | 7.35–7.45 | ---- | ---- | ---- | --- | --- | 7.49 | --- |
| pCO2 | 35–45 mmHg | ---- | ---- | ---- | --- | --- | 29.3 | --- |
| pO2 | 80–100 mmHg | ---- | ---- | ---- | --- | --- | 218.9 | --- |
| HCO3 | 22–26 mmole/L | ---- | --- | ---- | --- | --- | 22.0 | --- |
PT: prothrombin time; APTT: activated partial thromboplastin time; ALT: alanine aminotransferase; AST: aspartate aminotransferase.
Figure 2The chest X-ray revealed bilateral diffuse infiltration.
Figure 3The follow-up laboratory data progression in a clinical case of multiple organ failure.